FORT LAUDERDALE, FLORIDA / ACCESS Newswire / September 16, 2025 / 1606 Corp. (OTCID:CBDW) (the "Company"), under the leadership of CEO Austen Lambrecht, is pleased to announce that the Company will be attending the 151st National Investment Banking Association (NIBA) Conference, taking place in Fort Lauderdale, Florida on Tuesday, September 16th, 2025. As part of our ongoing growth strategy, 1606 Corp. is actively exploring mergers and acquisitions that align with our vision and expansion goals. ...

A Media Snippet accompanying this announcement is available by clicking on this link. DUBLIN, Sept. 16, 2025 (GLOBE NEWSWIRE) -- The American Academy of Sleep Medicine Foundation (AASM Foundation) and Avadel Pharmaceuticals are celebrating five years of collaboration and dedicated support for early-career sleep researchers and future sleep physicians. In 2021, Avadel became the Young Investigator Research Forum’s (YIRF) inaugural corporate sponsor. Thanks to support from Avadel and other companies, YIRF ha ...

GUANGZHOU, China, Sept. 16, 2025 (GLOBE NEWSWIRE) -- YSX TECH. CO., LTD (NASDAQ: “YSXT”) (the “Company”), a Cayman Islands exempted company that, through its variable interest entities in China, provides comprehensive business solutions mainly for insurance companies and brokerages in China, today announced that the Company and XUnit, a company that operates a real-world assets (“RWA”) and non-fungible token infrastructure platform deployed on X Layer, have entered into a memorandum of understanding (the “M ...

Accessibility StatementSkip Navigation Nuclear Fuels logo (CNW Group/Nuclear Fuels Inc.) Premier American Uranium logo (CNW Group/Nuclear Fuels Inc.) TORONTO, Sept. 16, 2025 /PRNewswire/ - Premier American Uranium Inc. ("PUR" or "Premier American Uranium") (TSXV: PUR) (OTCQB: PAUIF)Â and Nuclear Fuels Inc. ("NF" or "Nuclear Fuels") (CSE: NF) (OTCQX: NFUNF) are pleased to announce the completion of the previously announced arrangement (the "Arrangement") whereby Premier American Uranium has acquired all of t ...

SAN DIEGO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP) today announced the Company is in the process of addressing comments received by the U.S. Food and Drug Administration (FDA) in connection with the Company’s recent submission of an Orphan Drug Application (ODA) to the FDA for HemaXellerate, its lead therapeutic candidate for the treatment of aplastic anemia. Aplastic anemia is a rare and potentially life-threatening bone marrow disorder. The Company i ...

Dose optimization data from the Phase 1/2 study to be presented next month at ESMO 2025Second Fast Track designation granted by FDA for CRB-701 NORWOOD, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical stage oncology and obesity company, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to CRB-701 for the treatment of recurrent or metastatic head and neck squamous cell carc ...

CHARLOTTE, N.C., Sept. 16, 2025 /PRNewswire/ -- FG Nexus (Nasdaq: FGNX, FGNXP) (the "Company"), today announced that a majority of its shareholders have approved by written consent a landmark increase in authorized shares to 1 trillion shares, consisting of 900 billion common shares and 100 billion preferred shares, representing what we believe to be one of if not the largest share authorizations of any U.S. publicly traded company. The increase in authorized shares is not yet effective, but is expected to ...

LAGUNA HILLS, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), the first U.S. publicly listed company building a long-term strategic treasury of Hyperliquid’s native token, HYPE, today announced its first HYPE Asset Use Service (“HAUS”) agreement with proprietary trading firm Credo Cayman (“Credo”). Through this first-of-its-kind on-chain service, Hyperion DeFi provides the use of 100,000 staked HYPE to Credo, enabling the firm to substantiall ...

Dose optimization data from the Phase 1/2 study to be presented next month at ESMO 2025Second Fast Track designation granted by FDA for CRB-701 NORWOOD, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical stage oncology and obesity company, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to CRB-701 for the treatment of recurrent or metastatic head and neck squamous cell carc ...

Decade Resources Reports Mineralized Quartz Veins and Porphyry Indicators at North Mitchell Property, Golden Triangle, BCSeptember 16, 2025 8:00 AM EDT | Source: Decade Resources Ltd.Stewart, British Columbia--(Newsfile Corp. - September 16, 2025) - Decade Resources Ltd. (TSXV: DEC) ("Decade" or the "Company") is pleased to report results from a recent reconnaissance program on the North Mitchell Property, located approximately 7 km north of Newmont's Brucejack Mine and east of Seabridge Gold' ...